The Food and Drug Administration has revealed that the maker of a brand of eye drops linked to an outbreak of fatal bacterial infections failed to follow multiple safety protocols.
The FDA visited a Global Pharma Healthcare facility in India for an inspection in mid-February and found dozens of issues ranging from dirty equipment and clothing to missing safeguards and procedures.
The inspection came two-and-a-half weeks after the company voluntarily recalled the EzriCare artificial tears product because of possible contamination.
When the recall was issued, there were already 55 reports of adverse events, including eye infections, permanent loss of vision, and at least one death from a bloodstream infection.
SpaceX Investor Chad Anderson discusses Starship's latest test flight, what's next, and why he thinks Elon Musk's leadership sent the company in the right direction.
Dilip Rao, CEO of Sharebite, explains how his startup wants to normalize companies feeding their workers, the role of the private sector in public concerns, and more.
Athlete compensation, player unions and realignment dominate discussions — everything in college sports is open for discussion, interpretation and adjustment.
Sola Mahfouz and Malaina Kapoor, authors of 'Defiant Dreams: The Journey of an Afghan Girl Who Risked Everything for Education' discuss how Sola overcame the Taliban to get an education.
Pittsburgh International Airport CEO, Christina Cassotis talks the airport’s upcoming upgrades and why you can’t count out business travel, even in a post-pandemic world.
